Whole-genome gene expression modifications associated with nitrosamine exposure and micronucleus frequency in human blood cells

Mutagenesis

Volumn 26, Issue 6, 2011, Pages 753-761

  Hebels, Dennie G A J ^a   Jennen, Danyel G J ^a   Van Herwijnen, Marcel H M ^a   Moonen, Edwin J C ^a   Pedersen, Marie ^a,b   Knudsen, Lisbeth E ^a,b   Kleinjans, Jos C S ^a   De Kok, Theo M C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 NITROSOPIPERIDINE; BUB3 PROTEIN; CASPASE 2; CASPASE 8; DIMETHYLNITROSAMINE; F BOX AND WD REPEAT DOMAIN CONTAINING 7 PROTEIN; F BOX PROTEIN; HUNTINGTIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NITROSAMINE; SMAD3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CARCINOGENICITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENOME ANALYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; MICROARRAY ANALYSIS; MICRONUCLEUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; URINE LEVEL;

ADULT; BLOOD CELLS; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; NITROSAMINES; SIGNAL TRANSDUCTION;

EID: 80455149694     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger043     Document Type: Article

References (55)

1. Druckrey, H., Preussmann, R., Ivankovic, S. et al. (1967) Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats. Z. Krebsforsch., 69, 103-201.
2. IARC (2010) Agents Classified by the IARC Monographs, Volumes 1-100. http://monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrder. pdf (accessed February 5, 2011).
3. Scanlan, R. A. and Barbour, J. F. (1991) N-nitrosodimethylamine content of US and Canadian beers. IARC Sci. Publ., 105, 242-243.
4. Kuhnle, G. G. and Bingham, S. A. (2007) Dietary meat, endogenous nitrosation and colorectal cancer. Biochem. Soc. Trans., 35, 1355-1357.
5. Tricker, A. R. (1997) N-nitroso compounds and man: Sources of exposure, endogenous formation and occurrence in body fluids. Eur. J. Cancer Prev., 6, 226-268.
6. Rao, T. K., Lijinsky, W. and Epler, J. L. (eds.) (1984) Genotoxicology of N-Nitroso Compounds. Plenum Press, New York, NY.
7. Brambilla, G., Cavanna, M., Pino, A. et al. (1981) Quantitative correlation among DNA damaging potency of six N-nitroso compounds and their potency in inducing tumor growth an bacterial mutations. Carcinogenesis, 2, 425-429.
8. Knekt, P., Jarvinen, R., Dich, J. et al. (1999) Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: A follow-up study. Int. J. Cancer, 80, 852-856.
9. Mirvish, S. S. (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett., 93, 17-48.
10. de Roos, A. J., Ward,M. H., Lynch, C. F. et al. (2003) Nitrate in public water supplies and the risk of colon and rectum cancers. Epidemiology, 14, 640-649.
11. Jakszyn, P., Bingham, S., Pera, G. et al. (2006) Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPICEURGAST) study. Carcinogenesis, 27, 1497-1501.
12. Hebels, D. G., Jennen, D. G., Kleinjans, J. C. et al. (2009) Molecular signatures of N-nitroso compounds in Caco-2 cells: Implications for colon carcinogenesis. Toxicol. Sci., 108, 290-300.
13. van Leeuwen, D. M., Pedersen, M., Hendriksen, P. J. et al. (2008) Genomic analysis suggests higher susceptibility of children to air pollution. Carcinogenesis, 29, 977-983.
14. van Leeuwen, D. M., Gottschalk, R. W., Schoeters, G. et al. (2008) Transcriptome analysis in peripheral blood of humans exposed to environmental carcinogens: A promising new biomarker in environmental health studies. Environ. Health Perspect., 116, 1519-1525.
15. Mostafa, M. H., Helmi, S., Badawi, A. F. et al. (1994) Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis, 15, 619-625.
16. Merlo, D. F., Wild, C. P., Kogevinas, M. et al. (2009) NewGeneris: A European study on maternal diet during pregnancy and child health. Cancer Epidemiol. Biomarkers Prev., 18, 5-10.
17. Pedersen, M., Wichmann, J., Autrup, H. et al. (2009) Increased micronuclei and bulky DNA adducts in cord blood after maternal exposures to trafficrelated air pollution. Environ. Res., 109, 1012-1020.
18. Lijinsky, W. (1992) Chemistry and Biology of N-Nitroso Compounds. Cambridge Univ. Press, Cambridge, UK.
19. Mirvish, S. S., Haorah, J., Zhou, L. et al. (2003) N-nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef. Carcinogenesis, 24, 595-603.
20. Spiegelhalder, B., Eisenbrand, G. and Preussmann, R. (1980) Volatile nitrosamines in food. Oncology, 37, 211-216.
21. Bonassi, S., Znaor, A., Ceppi, M. et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631.
22. El-Zein, R. A., Fenech, M., Lopez, M. S. et al. (2008) Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol. Biomarkers Prev., 17, 1111-1119.
23. Mehta, R., Silinskas, K. C., Zucker, P. F. et al. (1987) Micronucleus formation induced in rat liver and esophagus by nitrosamines. Cancer Lett., 35, 313-320.
24. Vermeer, I. T., Pachen, D. M., Dallinga, J. W. et al. (1998) Volatile Nnitrosamine formation after intake of nitrate at the ADI level in combination with an amine-rich diet. Environ. Health Perspect., 106, 459-463.
25. Decordier, I., Papine, A., Plas, G. et al. (2009) Automated image analysis of cytokinesis-blocked micronuclei: An adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis, 24, 85-93.
26. Kirsch-Volders,M., Plas, G., Elhajouji, A. et al. (2011) The in vitroMNassay in 2011: Origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch. Toxicol., Doi:10.1007/ s00204-011-0691-4.
27. Fenech, M., Chang, W. P., Kirsch-Volders, M. et al. (2003) HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res., 534, 65-75.
28. Chen, X., Ender, P., Mitchell, M. et al. (2003) SPSS Web Books. http:// www.ats.ucla.edu/stat/spss/webbooks/reg/default.htm (accessed February 26, 2011).
29. Shi, L., Reid, L. H., Jones, W. D. et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24, 1151-1161.
30. Ekins, S., Nikolsky, Y., Bugrim, A. et al. (2007) Pathway mapping tools for analysis of high content data. Methods Mol. Biol., 356, 319-350.
31. van Leeuwen, D. M., Pedersen, M., Knudsen, L. E. et al. (2011) Transcriptomic network analysis of micronuclei-related genes: A case study. Mutagenesis, 26, 27-32.
32. Georgiadis, P., Samoli, E., Kaila, S. et al. (2000) Ubiquitous presence of O6-methylguanine in human peripheral and cord blood DNA. Cancer Epidemiol. Biomarkers Prev., 9, 299-305.
33. Speit, G., Zeller, J. and Neuss, S. (2011) The in vivo or ex vivo origin of micronuclei measured in human biomonitoring studies. Mutagenesis, 26, 107-110.
34. Arranz, N., Haza, A. I., Garcia, A. et al. (2008) Inhibition by vitamin C of apoptosis induced by N-nitrosamines in HepG2 and HL-60 cells. J. Appl. Toxicol., 28, 788-796.
35. Uhl, M., Helma, C. and Knasmuller, S. (1999) Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. Mutat. Res., 441, 215-224.
36. Raucy, J. L., Schultz, E. D., Wester, M. R. et al. (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab. Dispos., 25, 1429-1435.
37. Thomas, P. and Fenech, M. (2011) Cytokinesis-block micronucleus cytome assay in lymphocytes. Methods Mol. Biol., 682, 217-234.
38. Kim, B. M., Choi, J. Y., Kim, Y. J. et al. (2007) Reoxygenation following hypoxia activates DNA-damage checkpoint signaling pathways that suppress cell-cycle progression in cultured human lymphocytes. FEBS Lett., 581, 3005-3012.
39. Aaronson, D. S. and Horvath, C. M. (2002) A road map for those who don't know JAK-STAT. Science, 296, 1653-1655.
40. Bustelo, X. R., Sauzeau, V. and Berenjeno, I. M. (2007) GTP-binding proteins of the Rho/Rac family: Regulation, effectors and functions in vivo. Bioessays, 29, 356-370.
41. Oda, K., Matsuoka, Y., Funahashi, A. et al. (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol., 1, 2005 0010.
42. Annola, K., Heikkinen, A. T., Partanen, H. et al. (2009) Transplacental transfer of nitrosodimethylamine in perfused human placenta. Placenta, 30, 277-283.
43. Ward, M. H., deKok, T. M., Levallois, P. et al. (2005) Workgroup report: Drinking-water nitrate and health-recent findings and research needs. Environ. Health Perspect., 113, 1607-1614.
44. Haggerty, H. G. and Holsapple, M. P. (1990) Role of metabolism in dimethylnitrosamine-induced immunosuppression: A review. Toxicology, 63, 1-23.
45. Suzuki, Y., Takagi, R., Kawasaki, I. et al. (2008) The micronucleus test and erythropoiesis: Effects of cyclic adenosine monophosphate (cAMP) on micronucleus formation. Mutat. Res., 655, 47-51.
46. Herzig, S., Hedrick, S., Morantte, I. et al. (2003) CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature, 426, 190-193.
47. Li, A., Dubey, S., Varney, M. L. et al. (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol., 170, 3369-3376.
48. Smollich, M. and Wulfing, P. (2008) Targeting the endothelin system: Novel therapeutic options in gynecological, urological and breast cancers. Expert Rev, Anticancer Ther., 8, 1481-1493.
49. Waeber, C., Blondeau, N. and Salomone, S. (2004) Vascular sphingosine- 1-phosphate S1P1 and S1P3 receptors. Drug News Perspect., 17, 365-382.
50. Vineis, P. and Perera, F. (2007) Molecular epidemiology and biomarkers in etiologic cancer research: The new in light of the old. Cancer Epidemiol. Biomarkers Prev., 16, 1954-1965.
51. Conkright, M. D. and Montminy, M. (2005) CREB: The unindicted cancer co-conspirator. Trends Cell Biol., 15, 457-459.
52. Curry, C. L., Reed, L. L., Broude, E. et al. (2007) Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol. Cancer Ther., 6, 1983-1992.
53. Kalitsis, P., Earle, E., Fowler, K. J. et al. (2000) Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev., 14, 2277-2282.
54. Raghavachari, N., Xu, X., Munson, P. J. et al. (2009) Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease. PLoS One, 4, e6484.
55. Huang, J., Shi, W., Zhang, J. et al. (2010) Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J, 10, 267-277.